Recent Content
- Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis
- Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
- Matrine induces autophagic cell death by triggering ROS/AMPK/mTOR axis and apoptosis in multiple myeloma
- Efficacy Analysis of Bortezomib Combined with Lenalidomide in Newly Diagnosed Multiple Myeloma with 1q21 Gain/Amp
- Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
- Tecvayli Effective in BCMA-Pretreated R/R Multiple Myeloma
- Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature
- The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
- Changes in the intestinal microbiota of multiple myeloma patients living in high-altitude and cold regions analyzed using 16s rRNA high-throughput sequencing
- The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation